Meet The Future
Of Healthcare

Dock automates clinical documentation. Starting in emergency care, Dock’s point-of-care, disposable timers reflect hospital protocols, increase protocol adherence, and improve patient outcomes. Timer data is fed into the INSIGHT System providing real-time risk stratification, quick reporting, and more.

SPIRE develops treatments for patients with challenging brain function disorders in mental health and neurodegenerative conditions. Their Diadem platform uses noninvasive ultrasound to target deep brain circuits involved in these disorders without requiring drugs or invasive procedures.

Snow Canyon Therapeutics is discovering and developing novel treatments that reverse and repair the damage caused by inflammation and inflammatory diseases. By understanding a molecular pathway that controls inflammation and cellular stress responses  Snow Canyon is targeting Osteoarthritis and other chronic conditions.

Monere is developing novel AI solutions to revolutionize medical screening for anemia and improve health care efficiency across the globe. Their flagship product, the Non-invasive Anemia Detection w/ AI (NiADA), aims to detect and manage Anemia in oncology patients and women using your smartphone.

SymbioCellTech, LLC (SCT) is a late preclinical bio-cellular company in Salt Lake City, Utah, developing Neo-Islets™ for Type 1 Diabetes. Founded by academic investigators, SCT is preparing for IND submission after successful animal studies, including a three-year INAD dog study. Neo-Islets™ demonstrated safety and produced 0.8-1.2 Insulin Units/kg Body Weight/Day, aiming to reduce or eliminate daily insulin injections and associated complications in Type 1 Diabetes patients.

3Helix specializes in a first-of-its-kind platform technology called Collagen Hybridizing Peptides (CHPs) that allow for the targeting of damaged collagen. Their lead products include an atopic dermatitis therapeutic, cosmetics active ingredients, and a NASH diagnostic.

Aumenta Bio is creating injectable immune-boosting cancer treatments to address the limitations of oral probiotics and microbiome therapies. Their main product has shown remarkable effectiveness when used with checkpoint inhibitors and by itself in various solid tumor studies.

Rebel Medicine is generating safe and effective alternatives to opioids for acute pain management through innovative drug delivery science. Their flagship produce, Alevatrix, provides 3-4 days of postoperative pain relief.

Leash Biosciences is a discovery-stage biotechnology company that seeks to engineer small molecule selectivity. They combine DNA-encoded library screening with a proteome-scale target space and world-class machine-learning approaches to identify future medicines.

iMessa Research is transforming the separation, purification, and characterization of bio nanoparticles with a new generation of environmentally-friendly and affordable instruments, aligning with advancements in biomanufacturing. Their products aim at quality control and research and development laboratories of pharmaceutical companies and research institutes.

Vistim Labs uses AI to advance neurodegenerative disease diagnostics, improving patient outcomes by accelerating brain damage diagnosis and predicting clinical endpoints like atrophy and amyloid/tau accumulation.

Teiko Bio is an immune profiling lab serving drug developers and physicians. They provide detailed immune state reports to drug developers conducting high-risk experiments to assess experimental medicines' effectiveness. Their blood test predicts drug response based on a patient's unique immune profile.

Peel Therapeutics is an evolution-based, clinical-stage biotech company that intersects nature, curiosity, and science to transform patients' lives. They apply multidisciplinary scientific and drug development expertise to engineer evolutionary biology into medicines.